Literature DB >> 22001364

Decreased mRNA expression of uncoupling protein 2, a mitochondrial proton transporter, in post-mortem prefrontal cortex from patients with bipolar disorder and schizophrenia.

A D Gigante1, A C Andreazza, B Lafer, L N Yatham, C L Beasley, L T Young.   

Abstract

Although the neurobiological basis of bipolar disorder (BD) remains unknown, mitochondrial dysfunction, oxidative stress and oxidative cell damage have been identified in this disease. Uncoupling proteins (UCP) are proton carriers located in the inner membrane of the mitochondria involved in controlling the production of mitochondrial reactive oxygen species (ROS). Therefore, in this study we wished to investigate the involvement of UCP in BD. We analyzed the RNA and protein levels of UCP2 in the dorsolateral prefrontal cortex (DLPFC) of subjects with BD and schizophrenia (SCZ) and assessed the potential relationship between the antioxidant superoxide dismutase (SOD1 and SOD2) and UCP2 in the same region. Our results showed a downregulation of UCP2 mRNA levels in the DLPFC of subjects with BD and SCZ. There were no differences in UCP2 protein, SOD1 and SOD2 levels between patients and controls. Although more studies are necessary, our results suggest that UCP2 is not been used as a compensatory mechanism to oppose the higher levels of oxidative stress found in BD and SCZ.
Copyright © 2011 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22001364     DOI: 10.1016/j.neulet.2011.09.064

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  18 in total

1.  TSPO upregulation in bipolar disorder and concomitant downregulation of mitophagic proteins and NLRP3 inflammasome activation.

Authors:  Giselli Scaini; Tatiana Barichello; Gabriel R Fries; Elizabeth A Kennon; Taylor Andrews; Bobby R Nix; Giovana Zunta-Soares; Samira S Valvassori; Jair C Soares; João Quevedo
Journal:  Neuropsychopharmacology       Date:  2018-12-11       Impact factor: 7.853

2.  Omega-3 Fatty Acids and Mood Stabilizers Alter Behavioural and Energy Metabolism Parameters in Animals Subjected to an Animal Model of Mania Induced by Fenproporex.

Authors:  Kizzy Cancelier; Lara M Gomes; Milena Carvalho-Silva; Letícia J Teixeira; Joyce Rebelo; Isabella T Mota; Camila O Arent; Edemilson Mariot; Luiza W Kist; Maurício R Bogo; João Quevedo; Giselli Scaini; Emilio L Streck
Journal:  Mol Neurobiol       Date:  2016-05-31       Impact factor: 5.590

Review 3.  Increasing Nrf2 Activity as a Treatment Approach in Neuropsychiatry.

Authors:  G Morris; A J Walker; K Walder; M Berk; W Marx; A F Carvalho; M Maes; B K Puri
Journal:  Mol Neurobiol       Date:  2021-01-07       Impact factor: 5.590

4.  Omega-3 fatty acids alter behavioral and oxidative stress parameters in animals subjected to fenproporex administration.

Authors:  Camila S Model; Lara M Gomes; Giselli Scaini; Gabriela K Ferreira; Cinara L Gonçalves; Gislaine T Rezin; Amanda V Steckert; Samira S Valvassori; Roger B Varela; João Quevedo; Emilio L Streck
Journal:  Metab Brain Dis       Date:  2014-01-03       Impact factor: 3.584

5.  Update on the neurobiology of schizophrenia: a role for extracellular microdomains.

Authors:  D Shan; S Yates; R C Roberts; R E McCullumsmith
Journal:  Minerva Psichiatr       Date:  2012-09-01

6.  Sodium butyrate reverses the inhibition of Krebs cycle enzymes induced by amphetamine in the rat brain.

Authors:  Samira S Valvassori; Karen V Calixto; Josiane Budni; Wilson R Resende; Roger B Varela; Karolina V de Freitas; Cinara L Gonçalves; Emilio L Streck; João Quevedo
Journal:  J Neural Transm (Vienna)       Date:  2013-07-14       Impact factor: 3.575

7.  Decoupling of N-acetyl-aspartate and glutamate within the dorsolateral prefrontal cortex in schizophrenia.

Authors:  J M Coughlin; T Tanaka; A Marsman; H Wang; S Bonekamp; P K Kim; C Higgs; M Varvaris; R A E Edden; M Pomper; D Schretlen; P B Barker; A Sawa
Journal:  Curr Mol Med       Date:  2015       Impact factor: 2.222

Review 8.  Dendritic spine pathology in schizophrenia.

Authors:  J R Glausier; D A Lewis
Journal:  Neuroscience       Date:  2012-04-27       Impact factor: 3.590

9.  The Epigenetic Mechanisms of Amphetamine.

Authors:  Talus J McCowan; Archana Dhasarathy; Lucia Carvelli
Journal:  J Addict Prev       Date:  2015-02-09

10.  A hypothesis-driven association study of 28 nuclear-encoded mitochondrial genes with antipsychotic-induced weight gain in schizophrenia.

Authors:  Vanessa F Gonçalves; Clement C Zai; Arun K Tiwari; Eva J Brandl; Andriy Derkach; Herbert Y Meltzer; Jeffrey A Lieberman; Daniel J Müller; Lei Sun; James L Kennedy
Journal:  Neuropsychopharmacology       Date:  2013-11-07       Impact factor: 7.853

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.